Skip to content
DataLookout
Menu

ReMiNCT07931482

Revitalis - Midface (Cheek Area)

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Skin Smoothness: Responder status assessed by independent evaluator at site
Timeframe: week 12

Secondary (16)

Skin Smoothness: Responder status assessed by independent evaluator at site - other timepoints
Skin Smoothness: Responder status assessed by blinded panel
Skin Smoothness: Change from Baseline assessed by independent evaluator at site
Skin Smoothness: Change from baseline assessed by blinded panel
Cheek Lines: Responder Status assessed by independent evaluator at site
Show 11 moreShow less
Cheek Lines: Change from Baseline assessed by independent evaluator at site
Cheek Lines: Responder status assessed by blinded panel
Cheek Lines: Change from Baseline assessed by blinded panel
FACE-Q™ Satisfaction with Skin
FACE-Q™ Satisfaction with Outcome
FACE-Q™Lines Appraisal
GAIS assessed by the participants
GAIS assessed by an independent evaluator at site
Skin hydration: change from baseline
Skin elasticity: change from baseline
Skin firmness(tone): change from baseline

Arms and interventions

croma revitalisExperimental

Croma revitalis is a (CE)-marked, non-active, single-use hyaluronic acid-based medical device, intended for intradermal administration in the midface (cheek area).

Devices: Croma revitalis

Sites

1 site in 1 country

  • YuvellVienna, Austria